glp-1 obesity drug news updates Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Study finds GLP-1 receptor agonists

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Meisha.

Glucagon-like peptide-1 (GLP-1) is a natural hormone released in the intestines to regulate blood sugar levels and metabolism

Its important to talk with a healthcare provider about how long to use these medicines and make long-term healthy lifestyle changes to help keep weight off for good.What are the side effects?Common side effects include nausea, vomiting, diarrhea, abdominal pain, or constipation

Promotes a healthy blood sugar response*: Reducose slows down the breakdown of carbs to reduce post-meal glucose spikes by up to 40%, while Feiolix supports insulin sensitivity and glucose metabolism.

A smarter approach to appetite and metabolism